Clinical trials
5 active studies led by Beacon Therapeutics, of 14 in all
Source: ClinicalTrials.gov, Studies with Beacon Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Beacon Therapeutics in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Beacon Therapeutics or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
5 active studies led by Beacon Therapeutics, of 14 in all
Source: ClinicalTrials.gov, Studies with Beacon Therapeutics (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
2 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies Beacon Therapeutics leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Beacon Therapeutics or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Beacon Therapeutics: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Beacon Therapeutics is in.